Pseudomyxoma Peritonei Clinical Trials
3 recruiting trials for Pseudomyxoma Peritonei. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Pseudomyxoma Peritonei clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Universitaire Ziekenhuizen KU Leuven (1), Oslo University Hospital (1), Institut du Cancer de Montpellier - Val d'Aurelle (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Observational study. (other, 1 trial), followed by Cardiac coherence, Standard care.
Track Pseudomyxoma Peritonei trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.
Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
The aim of this study is to identify biomarkers of disease recurrence and prognosis to optimize patient selection for treatment with cytoreductive surgery (CRS) with hyperthermic...
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Pseudomyxoma Peritonei, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pseudomyxoma Peritonei, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pseudomyxoma Peritonei, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.